Julianna Lisziewicz

6.3k total citations · 1 hit paper
105 papers, 4.5k citations indexed

About

Julianna Lisziewicz is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Julianna Lisziewicz has authored 105 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Virology, 49 papers in Infectious Diseases and 40 papers in Immunology. Recurrent topics in Julianna Lisziewicz's work include HIV Research and Treatment (65 papers), HIV/AIDS drug development and treatment (38 papers) and Immunotherapy and Immune Responses (21 papers). Julianna Lisziewicz is often cited by papers focused on HIV Research and Treatment (65 papers), HIV/AIDS drug development and treatment (38 papers) and Immunotherapy and Immune Responses (21 papers). Julianna Lisziewicz collaborates with scholars based in United States, Italy and Hungary. Julianna Lisziewicz's co-authors include Franco Lori, Eric Rosenberg, Bruce D. Walker, Diana Finzi, Robert F. Siliciano, Thomas C. Quinn, Charles Flexner, Stephen J. Gange, Janet D. Siliciano and Joel N. Blankson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Julianna Lisziewicz

102 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1999 1.6k citations Julianna Lisziewicz, Franco Lori et al. profile →

Peers

Countries citing papers authored by Julianna Lisziewicz

Since Specialization

Citations

This map shows the geographic impact of Julianna Lisziewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julianna Lisziewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julianna Lisziewicz more than expected).

Fields of papers citing papers by Julianna Lisziewicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julianna Lisziewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julianna Lisziewicz. The network helps show where Julianna Lisziewicz may publish in the future.

Co-authorship network of co-authors of Julianna Lisziewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Julianna Lisziewicz. A scholar is included among the top collaborators of Julianna Lisziewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julianna Lisziewicz. Julianna Lisziewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Precision COVID-19 Vaccine with Companion Diagnostics 2020 ·SHILAP Revista de lepidopterología ·Julianna Lisziewicz, Franco Lori	4
2	HIV-1-Specific T Cell Precursors with High Proliferative Capacity Correlate with Low Viremia and High CD4 Counts in Untreated Individuals 2008 ·The Journal of Immunology ·Sandra A. Calarota, Andrea Foli, Renato Maserati, Fausto Baldanti, Stefania Paolucci, Mary Young, Christos Tsoukas, Julianna Lisziewicz, Franco Lori	40
3	Nanochemistry-Based Immunotherapy for HIV-1 2007 ·Current Medicinal Chemistry ·Franco Lori, Sandra A. Calarota, Julianna Lisziewicz	29
4	Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine 2007 ·Vaccine ·Sandra A. Calarota, David B. Weiner, Franco Lori, Julianna Lisziewicz	8
5	HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3 2007 ·Virology ·Anthony D. Cristillo, Julianna Lisziewicz, Leilei He, Franco Lori, Lindsey Galmin, Jeffrey Trocio, (unknown), Lucia Whitman, Lauren Hudacik, Nyasha Bakare, Stephen Whitney, (unknown), John J. Suschak, (unknown), (unknown), Vaniambadi S. Kalyanaraman, Phillip D. Markham, Ranajit Pal	27
6	The potential of topical DNA vaccines adjuvanted by cytokines 2007 ·Expert Opinion on Biological Therapy ·Julianna Lisziewicz, Sandra A. Calarota, Franco Lori	11
7	Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency 2005 ·AIDS Research and Human Retroviruses ·Franco Lori, Richard B. Pollard, Lucia Whitman, Nyasha Bakare, Gary Blick, (unknown), Andrea Foli, D. M. Peterson, Alan M. Tennenberg, Shannon Schrader, Bruce Rashbaum, Charles Farthing, (unknown), D. B. Norris, (unknown), Ian Frank, (unknown), (unknown), David M. Asmuth, Julianna Lisziewicz	9
8	DermaVir, a novel HIV immunisation technology 2005 ·Vaccine ·Franco Lori, Jeffrey Trocio, Nyasha Bakare, Libby A. Kelly, Julianna Lisziewicz	27
9	DermaVir: A Novel Topical Vaccine for HIV/AIDS 2005 ·Journal of Investigative Dermatology ·Julianna Lisziewicz, Jeffrey Trocio, Lucia Whitman, Georg Varga, Jianqing Xu, Nyasha Bakare, Patrick Erbacher, Cecil H. Fox, Ruth Woodward, Phil Markham, Suresh K. Arya, (unknown), Franco Lori	70
10	Topical DermaVir Vaccine Targeting Dendritic Cells 2005 ·Current Drug Delivery ·Julianna Lisziewicz, (unknown), Franco Lori	8
11	Short Communication: Methods of Using Interleukin 2 to Enhance HIV-Specific Immune Responses 2002 ·AIDS Research and Human Retroviruses ·Jianqing Xu, Lucia Whitman, Franco Lori, Julianna Lisziewicz	3
12	Direct analysis of mitochondrial toxicity of antiretroviral drugs 2001 ·AIDS ·Andrea Foli, Federica Benvenuto, Giampiero Piccinini, (unknown), Andrea Cossarizza, Julianna Lisziewicz, Franco Lori	60
13	Immune Restoration by Combination of a Cytostatic Drug (Hydroxyurea) and Anti-HIV Drugs (Didanosine and Indinavir) 1999 ·AIDS Research and Human Retroviruses ·Franco Lori, Heiko Jessen, Judy Lieberman, Mario Clerici, Carmine Tinelli, Julianna Lisziewicz	28
14	Conference Summary Targeting HIV Reservoirs and Reconstituting the Immune System 1999 ·AIDS Research and Human Retroviruses ·Franco Lori, Julianna Lisziewicz	2
15	New Uses for Old Drugs in HIV Infection 1999 ·Drugs ·(unknown), Julianna Lisziewicz, Franco Lori	31
16	Analysis of amino insertion mutations in the fingers subdomain of HIV-1 reverse transcriptase 1 1Edited by J. Karn 1999 ·Journal of Molecular Biology ·Paul L. Boyer, Julianna Lisziewicz, Franco Lori, Stephen H. Hughes	24
17	Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine. 1997 ·PubMed ·Andrea Foli, Franco Lori, Renato Maserati, Carmine Tinelli, L. Minoli, Julianna Lisziewicz	26
18	Mutations in thepolGene of Human Immunodeficiency Virus Type 1 in Infected Patients Receiving Didanosine and Hydroxyurea Combination Therapy 1997 ·The Journal of Infectious Diseases ·Anna De Antoni, Andrea Foli, Julianna Lisziewicz, Franco Lori	85
19	Hybrid oligonucleotides: Synthesis, biophysical properties, stability studies, and biological activity 1996 ·Bioorganic & Medicinal Chemistry ·Dong Yu, Radhakrishnan P. Iyer, Denise R. Shaw, Julianna Lisziewicz, Ying Li, Zhiwei Jiang, Allysen Roskey, Sudhir Agrawal	26
20	Transcriptional regulatory elements of the RAS2 gene of Saccharomyces cerevisiae 1990 ·Nucleic Acids Research ·Julianna Lisziewicz, J. Lesley Brown, Diego Breviario, Taduru Sreenath, (unknown), Richard Koller, Ravi Dhar	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact